SS
BLTE

SBI Securities’s Belite Bio BLTE Stock Holding History

SBI Securities’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39K Hold
22
– – ﹤0.01% 2349
2026
Q1 		$3.51K Sell
22
-28
-56% -$4.71K ﹤0.01% 2186
2025
Q4 		$8K Sell
50
-2
-4% -$237 ﹤0.01% 1814
2025
Q3 		$3.85K Hold
52
– – ﹤0.01% 2151
2025
Q2 		$3K Sell
52
-52
-50% -$3.17K ﹤0.01% 2225
2025
Q1 		$6.89K Buy
104
+90
+643% +$5.42K ﹤0.01% 1761
2024
Q4 		$883 Buy
+14
New +$923 ﹤0.01% 2669

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SBI Securities's BLTE Position: Q2 2026 in Review

SBI Securities held its Belite Bio (BLTE) position steady in Q2 2026 at 22 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

SBI Securities first reported a position in BLTE in Q4 2024 and has held it in 7 quarters since. The position peaked at $8K in Q4 2025. 12 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • SBI Securities held 22 shares of Belite Bio worth $3.39K as of Q2 2026.
  • SBI Securities left its Belite Bio share count unchanged in Q2 2026.
  • Belite Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2349 holding.
  • SBI Securities first reported a position in Belite Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Belite Bio position peaked at $8K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.